Announcements Trials
Browse Landscape

Phase

Phase NA 3

Status

Completed 9Terminated 3Recruiting 3Active not recruiting 2Unknown 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 4Tumor-Agnostic 3Breast 3Other hematologic neoplasm 2Genitourinary 2Thoracic 1Other solid neoplasm 1Other 1Head & Neck 1Dermatologic 1

Conditions

Neoplasms 3

Interventions

Gemcitabine 13pembrolizumab 12Capecitabine 9Irinotecan 8Erlotinib Hydrochloride 8Carboplatin 8Blood Specimen Collection 8Nivolumab 7Docetaxel 7Cisplatin 7Cetuximab 7Paclitaxel 6Everolimus 6130-nm albumin-bound paclitaxel 6vadimezan 5Magnetic Resonance Spectroscopy 5Fluorouracil 5Cyclophosphamide 5trametinib 4Leucovorin 4Lapatinib 4Ipilimumab 4Bevacizumab 4Albumin-Bound Paclitaxel 4temsirolimus 3atezolizumab 3abemaciclib 3Trastuzumab 3Radiotherapy 3Radiation 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Terminated × Methods × Tumor-Agnostic × Clear all
NCT05477784 2026-01-21

EC-PC

University of Washington

Phase NA Terminated
174 enrolled
Tumor-Agnostic

Neoplasms

NCT04278534 2023-08-30

Virtual Reality for the Education of Cancer Patients Undergoing Radiation Therapy

OHSU Knight Cancer Institute

Phase NA Terminated
27 enrolled
Tumor-Agnostic

Neoplasms

NCT02440737 2019-10-18

NEST

Vanderbilt-Ingram Cancer Center

Phase NA Terminated
67 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡